| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.43M | 16.72M | 12.06M | 5.93M | 1.49M | 1.49M |
| Gross Profit | 6.24M | 6.37M | 5.49M | 3.26M | 910.14K | 527.79K |
| EBITDA | 1.78M | 2.06M | -13.89M | -24.59M | -16.59M | 16.25M |
| Net Income | -6.76M | 1.23M | -14.15M | -28.59M | -19.43M | 19.92M |
Balance Sheet | ||||||
| Total Assets | 31.79M | 10.22M | 11.78M | 24.18M | 37.33M | 42.65M |
| Cash, Cash Equivalents and Short-Term Investments | 19.17M | 1.23M | 2.20M | 3.83M | 4.38M | 4.57M |
| Total Debt | 8.16M | 2.41M | 6.84M | 6.60M | 4.28M | 2.23M |
| Total Liabilities | 13.67M | 7.47M | 12.07M | 10.93M | 6.17M | 3.95M |
| Stockholders Equity | 21.18M | 6.13M | 3.96M | 13.97M | 27.38M | 32.94M |
Cash Flow | ||||||
| Free Cash Flow | -2.14M | -1.69M | -3.39M | -4.17M | -8.86M | -3.26M |
| Operating Cash Flow | -1.08M | -503.33K | -3.18M | -3.61M | -8.57M | -3.26M |
| Investing Cash Flow | -827.52K | -213.03K | 1.48M | -808.30K | -3.51M | -70.33K |
| Financing Cash Flow | 19.51M | -181.11K | 95.35K | 3.87M | 11.90M | 7.75M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
58 Neutral | C$89.07M | -7.82 | -10.97% | ― | 12.57% | -40.95% | |
50 Neutral | C$4.19M | -5.47 | ― | ― | -100.00% | 90.84% | |
44 Neutral | C$83.41M | -11.06 | -40.46% | ― | 52.23% | -300.60% | |
44 Neutral | C$60.75M | -6.37 | -10.10% | ― | 39.64% | -70.96% | |
43 Neutral | C$23.89M | -2.38 | ― | ― | -3.78% | 88.40% |
Victory Square Technologies Inc. reported its Q3 2025 financial results, highlighting significant growth and strategic developments across its portfolio. The company’s flagship digital health subsidiary, Hydreight, has been a key driver of success, achieving national recognition for its growth and innovation. Hydreight’s expansion into high-growth health segments and its robust compliance infrastructure position it well for continued success. Victory Square’s involvement in digital health initiatives and its economic participation through Hydreight’s platform underscore its strategic focus on scalable growth in the healthcare sector.
The most recent analyst rating on (TSE:VST) stock is a Hold with a C$0.72 price target. To see the full list of analyst forecasts on Victory Square Technologies Inc stock, see the TSE:VST Stock Forecast page.